The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
Chris Wakefield, Vice President, European Marketing & Product Development, GOJO Industries-Europe Ltd. explores the rise of presenteeism and how to mitigate its impact via good hand hygiene.
Nigel Hughes, Scientific Director at Observational Health Data Analytics, discusses EHDEN project in an environment of AI hype, socio-political unrest and healthcare demands.
Martin Warden, NHS Digital’s Programme Director for Digital Transformation in General Practice, charts the importance of the new GP IT Futures Digital Care Services framework.
Dr Deborah Lee, Specialist in Sexual & Reproductive Healthcare and Menopause, Dr Fox Online Pharmacy, discusses how the menopause may be affecting you at work.
According to Maximilian Kunisch and Giuseppe De Carlo from the European Federation of Allergies and Airways Diseases Patients' Associations, respiratory patients in Europe need to set the research priorities for asthma and chronic obstructive pulmonary disease (COPD).
Martin Seychell, Deputy Director-General for Health at the Directorate-General for Health and Food Safety (DG SANTE), explains why the European Commission cares about the digital transformation of healthcare.
Peter Jackson, Executive Director of the AMR Centre, describes new initiatives and partnerships that point the way forward for the UK’s antimicrobial resistance response.
Savage Cabbage Ltd offer their expert advice on what dosage of CBD users should be taking and answers other often asked questions, in this in-depth article.
As AI solutions are increasingly adopted in the healthcare sector, Dr Khalid Alyafei – Chief Medical Informatics Officer at Sidra Medicine in Qatar – discusses the benefits and challenges.
In the current moment, how severely is the viral misinformation online (from anti-vaccination movements to deadly 'miracle' cures) impacting the medical industry?
